Durvalumab vs Sumatriptan

## Durvalumab vs Sumatriptan: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Sumatriptan**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Sumatriptan**: Selective 5-HT1B/1D receptor agonist.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Sumatriptan — 2.5 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Sumatriptan — C14H21N3O2S.

**Molecular Weight**: Durvalumab — N/A; Sumatriptan — 295.4020 g/mol.

**Type**: Durvalumab — Antibody; Sumatriptan — Small molecule.